Ignite Creation Date:
2025-12-25 @ 1:19 AM
Ignite Modification Date:
2025-12-25 @ 11:27 PM
Study NCT ID:
NCT01121393
Status:
COMPLETED
Last Update Posted:
2018-12-14
First Post:
2010-04-21
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
BIBW 2992 (Afatinib) vs Gemcitabine-cisplatin in 1st Line Non-small Cell Lung Cancer (NSCLC)
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-04-19
Start Date Type:
ACTUAL
Primary Completion Date:
2017-11-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-11-26
Completion Date Type:
ACTUAL
First Submit Date:
2010-04-21
First Submit QC Date:
None
Study First Post Date:
2010-05-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-12-27
Results First Submit QC Date:
None
Results First Post Date:
2015-01-26
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-12-13
Last Update Post Date:
2018-12-14
Last Update Post Date Type:
ACTUAL